159eP Prognostic value of the immune checkpoint inhibitor score (IChIS) in palliative immunotherapy-treated non-small cell lung cancer: A real-world study
higher baseline Hb levels and improved survival further highlights the importance of host-related factors in determining immunotherapy outcomes.
Authors
- Doğan YAZILITAŞ
- İsmail Dilli (ORCID: https://orcid.org/0009-0005-9043-9790)
- Esra Zeynelgil (ORCID: https://orcid.org/0000-0001-7200-9440)
- Mehmetcan Atak
- S. Celik
- O. Aydin Isak
- E.E. Kavak
Institutions
- Memorial Ankara Hospital (TR)
Publication Details
- Journal
- ESMO Open
- Published
- 2026-03-17
- DOI
- https://doi.org/10.1016/j.esmoop.2026.106466
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00